- Report
- August 2026
- 110 Pages
Global
From €4290EUR$4,750USD£3,676GBP
- Report
- August 2026
- 130 Pages
Global
From €4290EUR$4,750USD£3,676GBP
- Report
- August 2026
- 117 Pages
Global
From €4290EUR$4,750USD£3,676GBP
- Report
- May 2026
- 140 Pages
Global
From €4290EUR$4,750USD£3,676GBP
- Report
- January 2026
- 220 Pages
Global
From €3161EUR$3,500USD£2,708GBP
- Report
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- May 2026
- 350 Pages
Global
From €4470EUR$4,949USD£3,830GBP
- Report
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- May 2026
- 350 Pages
Global
From €4470EUR$4,949USD£3,830GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- May 2026
- 200 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- May 2026
- 150 Pages
Global
From €2438EUR$2,699USD£2,089GBP
- Report
- May 2026
- 150 Pages
Global
From €2438EUR$2,699USD£2,089GBP
- Report
- May 2026
- 150 Pages
Global
From €2438EUR$2,699USD£2,089GBP
- Report
- May 2026
- 400 Pages
Global
From €4470EUR$4,949USD£3,830GBP
- Report
- October 2025
- 198 Pages
Global
From €4064EUR$4,500USD£3,482GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more